The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile
Byrd, John C., Wierda, William, Jones, Jeffrey, O'Brien, Susan, Brown, Jennifer R., Schuh, Anna, Hillmen, Peter, Stephens, Deborah M., Ghia, Paolo, Devereux, Steve, Chaves, Jorge M., Barrientos, Jacqueline C., Wang, Min Hui, Huang, Jane, Covey, Todd, Navarro, Tasheda, Rothbaum, Wayne, Izumi, Raquel, Hamdy, Ahmed, Furman, Richard R.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article